MedPath

Proposed cut-off CA19-9 values for detection of pancreatic cancer in patients with poorly glycemic controlled diabetes: a real-world study

Not Applicable
Conditions
diabetes mellitus, pancreatic cancer
Registration Number
JPRN-UMIN000049985
Lead Sponsor
Saiseikai Yokohamashi Nanbu Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
1060
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who refuse participating in research in response to opt-out notification Patients with malignant tumors requiring treatment currently

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Differences in CA19-9 values between patients with and without pancreatic cancer among patients with poorly glycemic controlled diabetes
Secondary Outcome Measures
NameTimeMethod
Cut-off CA19-9 values for detection of pancreatic cancer in poorly glycemic controlled patients with diabetes, and its sensitivity and specificity
© Copyright 2025. All Rights Reserved by MedPath